TP53 and breast carcinoma: For instance, studies in breast cancer cells revealed that 17β−E2 inhibited resveratrol-stimulated phosphorylation of Serines15, 20 and 392 of p53 and acetylation of p53 in a concentration-and time-dependent manner, and decreased apoptosis [49].